A number of other research firms have also commented on DAVA. Citigroup lowered their price target on shares of Endava from $44.00 to $42.00 and set a neutral rating on the stock in a research report on Friday, September 27th. Deutsche Bank raised their target price on shares of Endava from $36.00 to $43.00 and gave the company a hold rating in a report on Thursday, September 26th. KeyCorp began coverage on shares of Endava in a report on Thursday, June 6th. They issued a sector weight rating and a $38.26 target price on the stock. Finally, Zacks Investment Research lowered shares of Endava from a hold rating to a sell rating in a report on Tuesday, October 1st. Two research analysts have rated the stock with a sell rating and four have assigned a hold rating to the stock. Endava currently has a consensus rating of Hold and a consensus target price of $38.85.
NYSE:DAVA traded up $0.29 during mid-day trading on Wednesday, reaching $37.83. 46,530 shares of the company’s stock were exchanged, compared to its average volume of 103,486. Endava has a one year low of $21.13 and a one year high of $43.93. The firm has a market capitalization of $1.99 billion, a PE ratio of 38.21, a price-to-earnings-growth ratio of 2.42 and a beta of 0.74. The business’s fifty day simple moving average is $37.59 and its two-hundred day simple moving average is $35.32.
Endava Company Profile
Endava plc provides technology services for clients in the consumer products, healthcare, logistics, and retail verticals in Europe, Latin America, and the United States. It offers strategy, creative and user experience, insights through data, mobile and Internet of Things, architecture, smart automation, software engineering, test automation and engineering, continuous delivery, cloud, applications management, and smart desk services across the digital evolution, agile transformation, and automation solution areas.
Featured Story: Operating Income
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Endava Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endava and related companies with MarketBeat.com's FREE daily email newsletter.